Liver Disease Drugs Research
3 comprehensive market analysis studies and research reports on the Liver Disease Drugs sector, offering an overview with historical data since 2019 and forecasts up to 2030. This includes a detailed market research of 50 companies, enriched with industry statistics, insights, and a lot more.

Healthcare
Categories
3 Healthcare Reports
Categories
Filters and Sort
Showing 3 of 3 results in Liver Disease Drugs
Ursodeoxycholic Acid Market
CAGR: 7.74%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia Pacific, Middle East and Africa, South America
Major Players:Teva Pharmaceutical Industries, Dr. Falk Pharma GmbH, Daewoong Pharmaceutical (INDIA) Pvt. Ltd., Grindeks, Apotex
Liver Diseases Therapeutics Market
CAGR: 7.09%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Abbott Laboratories, Novartis, Gilead Sciences, Sanofi, Astellas Pharma
Primary Biliary Cholangitis Therapeutics Market
CAGR: 7.86%
Study Period: 2020 - 2031
Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America
Major Players:Abbvie, Glenmark Pharmaceuticals, Intercept Pharmaceuticals, Teva Pharmaceutical Industries, Viatris (Mylan)
Yay! You have seen it all
CONTACT US
When decisions matter, industry leaders turn to our analysts. Let’s talk.


_Therapeutics_COmpanies.webp&w=500&q=75)